1063-P: Impact of Mobile Messaging on Follow-up and Glycemic Control in the Indian Population

Abstract

Introduction: Diabetes treatment requires the involvement of people with diabetes in the form of regular clinical follow-up for good Glycaemic control and Metabolic health. Newer Communication techniques, such as mobile messaging are now finding their way into diabetes care and treatment. It can assist diabetes patients to maintain a regular follow-up routine and can assist in glycemic control. Materials and Methods: A total of 326 patients were selected by random sampling. They were of age 15-65 years with T1DM and T2DM. Inclusion Criteria: 1. Known case of DM 2. Consent to receive messages Exclusion criteria: 1. Not consenting for messaging 2. Reading Disability. Randomly allocated to two groups of 163 persons each. In the first group, the participants were sent regular messages to remind them of their follow-up dates. The other group was treated as usual and was allowed to come for follow-up on their own. The participants were monitored for follow-up frequency, meeting testing deadlines and resultant glycemic control measured by Hba1c at 3 months and 6 months. The results were tabulated and analysed using SPSS. Result: 17 patients each dropped out from the messaging group and 16 patients dropped out from routine care groups, out of the remaining 297 patients the analysis of data shows: in the messaging group, 63 % maintained their follow-up dates as compared to 42 % in the other group. The number of patients achieving the target goal of 7% HBA1C was better in the messaging group (54%) as compared to the routine group (31%). Blood sugar testing frequency was better in the messaging group as compared to other group. Discussion: With the advent of newer modalities of communication, the ways and means to communicate with patients has improved. These tools if used correctly can not only improve follow-ups but at the same time increase the connection between caregivers and patients. This also can result in better patient outcomes and will lead to reduced complications and financial implications. Disclosure B.Saboo: None. S.Saboo: None. V.Chavda: None. D.Hasnani: None.